Diseases of Prostate Flashcards

(35 cards)

1
Q

How big is prostate

A

20cc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the Prostatic Zones called

A

McNeal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is Benign Prostatic Hyperplasia characterised by

A

FIbromuscular and Glandular Hyperplasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Benign Prostatic Hyperplasia affects

A

Transition Zone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Benign Prostatic Hyperplasia is disordered regulation of

A

Dihydrotestosterone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

50% of men with BPH have moderate to severe

A

LUTS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Benign Prostatic Hyperplasia can result in

A

BPO or BOO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

International Prostate Symptom Score Sheet Mild

A

0-7

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

International Prostate Symptom Score Sheet Moderate

A

8-19

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

International Prostate Symptom Score Sheet Severe

A

> 20

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Tests for Benign Prostatic Hyperplasia

A
MSSU
Flow Rate Study
Post Void Bladder Residual USS
Bloods: PSA
Urea and Creatinine (chronic retention)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

If renal failure suspected test

A

renal tract uss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

if bladder stone suspected test

A

renal tract uss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

if haematuria test

A

flexible cystoscopy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

if psa raised test or abnormal DRE

A

TRUS guided prostate biopsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what medication can be used for risk factors of prostate obstruction

A

5 alpha reductase inhibitor

alpha blocker

17
Q

Treatment of uncomplicated BPO medical

A

5 alpha reductase inhibitor

alpha blockers

18
Q

treatment of uncomplicated boo surgical

A

turn if prostate <100

open retropubic or transvesical prostatectomy if prostate >100

19
Q

name 2 5 alpha reductase inhibitors that could be used for uncomplicated boo

A

finasteride or dutasteride

20
Q

Alpha Blockers are

A

main treatment for LUTS due to BPO

21
Q

Smooth muscle of bladder neck and prostate are innervated by

A

sympathetic alpha adrenergic nerves (Alpha 1)

22
Q

What do alpha blockers do in prostate disease

A

cause smooth muscle relaxation and antagonist

23
Q

Non Selective Alpha Blockers examples

A

phenoxybenzamine

24
Q

Selective short acting alpha blockers examples

A

proposing, indoramin

25
selective long acting alpha blockers examples
alfuzosin, doxazosin
26
highly selective alpha blockers examples
tamsulosin
27
what do 5a reductase inhibitors do
convert testosterone to dihydrotestosterone
28
which 5a reductase inhibitors available for uncomplicated bpo
finasteride (type 2 inhibitor) | dutarsteride (type 1 and type 2 inhibitor)
29
role of 5a reductase inhibitors in prostate disease
reduce prostate size reduce risk of progression of BPE if prostate >25cc Reduces LUtS but alpha blockers better for this potential role in prostate cancer prevention
30
Gold standard for BPO
TURP
31
Treatment of complicated BPO
No role for medical therapy except for acute urinary retention Cystolitholapaxy and TURP for patients with BPO and bladder stones Catherisation
32
The following are absolute indications for surgical intervention in patients with benign prostatic obstruction except: a. refractory acute urinary retention b. refractory chronic urinary retention c. renal failure d. recurrent UTI e. bladder stones
b. refractory chronic urinary retention
33
The following are causes of acute urinary retention in men except: a. spinal cord compression b. urinary tract infection c. constipation d. pain from laparotomy wound e. cystoscopy under local anaesthetic
e. cystoscopy under local anaesthetic
34
3. Short-term urethral catheters (e.g. latex-based ones) should not be left in-situ for longer than: a. 1 week b. 4 weeks c. 8 weeks d. 12 weeks e. 16 weeks
b 4 weeks
35
Long-term urethral catheters (e.g. silicone-based ones) should not be left in-situ for longer than: a. 1 week b. 4 weeks c. 8 weeks d. 12 weeks e. 16 weeks
12 weeks